Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Galloway DA, Daling JR, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2013 Jul;133(1):201-13. doi: 10.1002/ijc.28000. Epub 2013 Feb 12.

2.

A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers.

Hardikar S, Johnson LG, Malkki M, Petersdorf EW, Galloway DA, Schwartz SM, Madeleine MM.

Gynecol Oncol. 2015 Oct;139(1):90-6. doi: 10.1016/j.ygyno.2015.07.110. Epub 2015 Aug 1.

3.

Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Galloway DA, Malkki M, Petersdorf EW, Schwartz SM.

Int J Cancer. 2014 Jan 15;134(2):437-44. doi: 10.1002/ijc.28364. Epub 2013 Aug 5.

4.

Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.

Bodelon C, Madeleine MM, Johnson LG, Du Q, Malkki M, Petersdorf EW, Schwartz SM.

Gynecol Oncol. 2012 Mar;124(3):525-8. doi: 10.1016/j.ygyno.2011.11.017. Epub 2011 Nov 28.

5.

Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in Chinese women.

Chen X, Han S, Wang S, Zhou X, Zhang M, Dong J, Shi X, Qian N, Wang X, Wei Q, Shen H, Hu Z.

Clin Cancer Res. 2009 Jan 1;15(1):400-5. doi: 10.1158/1078-0432.CCR-08-1829.

6.

Effect of anti-inflammatory (IL-4, IL-10) cytokine genes in relation to risk of cervical carcinoma.

Shekari M, Kordi-Tamandani DM, MalekZadeh K, Sobti RC, Karimi S, Suri V.

Am J Clin Oncol. 2012 Dec;35(6):514-9. doi: 10.1097/COC.0b013e31822d9c12.

PMID:
22157213
7.

Cervical and vulvar cancer risk in relation to the joint effects of cigarette smoking and genetic variation in interleukin 2.

Hussain SK, Madeleine MM, Johnson LG, Du Q, Malkki M, Wilkerson HW, Farin FM, Carter JJ, Galloway DA, Daling JR, Petersdorf EW, Schwartz SM.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1790-9. doi: 10.1158/1055-9965.EPI-07-2753.

8.

Genetic variation in CXCL12 and risk of cervical carcinoma: a population-based case-control study.

Maley SN, Schwartz SM, Johnson LG, Malkki M, Du Q, Daling JR, Li SS, Zhao LP, Petersdorf EW, Madeleine MM.

Int J Immunogenet. 2009 Dec;36(6):367-75. doi: 10.1111/j.1744-313X.2009.00877.x. Epub 2009 Sep 24.

9.

Functional polymorphisms in the interleukin-12 gene contribute to cancer risk: evidence from a meta-analysis of 18 case-control studies.

Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q.

Gene. 2012 Nov 15;510(1):71-7. doi: 10.1016/j.gene.2012.08.019. Epub 2012 Aug 25.

PMID:
22940148
11.

Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.

Torres-Poveda K, Burguete-García AI, Bahena-Román M, Méndez-Martínez R, Zurita-Díaz MA, López-Estrada G, Delgado-Romero K, Peralta-Zaragoza O, Bermúdez-Morales VH, Cantú D, García-Carrancá A, Madrid-Marina V.

BMC Cancer. 2016 May 24;16:330. doi: 10.1186/s12885-016-2364-4.

12.

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.

Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB.

Am J Hum Genet. 2007 Feb;80(2):273-90. Epub 2006 Dec 21.

13.

Lack of association between polymorphisms in interleukin (IL)-12, IL-12R, IL-23, IL-23R genes and Takayasu arteritis in a Chinese population.

Yang KQ, Yang YK, Meng X, Zhang Y, Jiang XJ, Wu HY, Zhang HM, Song L, Bian J, Wen D, Wang LP, Zhou XL.

Inflamm Res. 2016 Jul;65(7):543-50. doi: 10.1007/s00011-016-0938-x. Epub 2016 Mar 17.

PMID:
26987707
14.

Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer.

Roszak A, Mostowska A, Sowińska A, Lianeri M, Jagodziński PP.

Pathol Oncol Res. 2012 Oct;18(4):997-1002. Epub 2012 May 22.

PMID:
22614250
15.

Association of single nucleotide polymorphisms in interleukin 12 (IL-12A and -B) with asthma in a Chinese population.

Chen T, Liang W, Gao L, Wang Y, Liu Y, Zhang L, Zhang L.

Hum Immunol. 2011 Jul;72(7):603-6. doi: 10.1016/j.humimm.2011.03.018. Epub 2011 Apr 8.

PMID:
21513752
16.

Single nucleotide polymorphism in the interleukin 12B gene is associated with risk for breast cancer development.

Kaarvatn MH, Vrbanec J, Kulic A, Knezevic J, Petricevic B, Balen S, Vrbanec D, Dembic Z.

Scand J Immunol. 2012 Sep;76(3):329-35. doi: 10.1111/j.1365-3083.2012.02736.x.

17.

Interleukin 10 polymorphisms and cervical cancer risk: a meta-analysis.

Ni J, Ye Y, Teng F, Wu Q.

Int J Gynecol Cancer. 2013 Jan;23(1):126-33. doi: 10.1097/IGC.0b013e318274b1a2.

PMID:
23095823
18.

Association of single nucleotide polymorphisms in the IL-12 (IL-12A and B) and IL-12 receptor (IL-12Rbeta1 and beta2) genes and gene-gene interactions with atopic dermatitis in Koreans.

Namkung JH, Lee JE, Kim E, Kim S, Kim S, Shin ES, Cho EY, Yang JM.

J Dermatol Sci. 2010 Mar;57(3):199-206. doi: 10.1016/j.jdermsci.2009.12.003. Epub 2010 Jan 8.

PMID:
20060272
19.

Risk of cervical cancer associated with allergies and polymorphisms in genes in the chromosome 5 cytokine cluster.

Johnson LG, Schwartz SM, Malkki M, Du Q, Petersdorf EW, Galloway DA, Madeleine MM.

Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):199-207. doi: 10.1158/1055-9965.EPI-10-0779. Epub 2010 Nov 11.

20.

Interactions of interleukin-12A and interleukin-12B polymorphisms on the risk of intracranial aneurysm.

Li LJ, Pan XM, Sima X, Li ZH, Zhang LS, Sun H, Zhu Y, Liang WB, Gao LB, Zhang L.

Mol Biol Rep. 2012 Dec;39(12):11217-23. doi: 10.1007/s11033-012-2031-z. Epub 2012 Oct 12.

PMID:
23065210

Supplemental Content

Support Center